Medtronic reports 40% increase in Q2 FY25 net income to $1.27bn
The medical device maker reported net sales of $8.4bn for Q2 FY25, a 5% increase compared to $7.98bn for Q2 FY24, and a 6% rise compared to $7.91bn for the...
DexCom and ŌURA partner to integrate glucose and biometric tracking
Health Canada approves Aktiia’s blood pressure monitoring bracelet
Stryker unveils Oculan Lighting Platform to enhance surgical visualisation and illumination
LogicMark launches revolutionary medical alert device, Freedom Alert Max, offering cellular communication technology and 24/7 assistance
Lunit partners with AstraZeneca to develop AI-powered cancer diagnostics
Analysis
View More
Risks
View MoreNavigating the impact of interstate armed conflict on the medical device development industry
By understanding and preparing for the potential impacts of geopolitical instability, medical device companies can enhance their resilience and continue to deliver critical healthcare solutions in an increasingly complex global...
More Risks
White Papers
View More
Societal polarisation and its impact on the medical device development industry
Addressing the challenges posed by extreme weather events in the medical device development industry
Economic downturn: challenges and opportunities in the medical device development industry
Biodiversity loss and ecosystem collapse: the impact on the medical device development industry